Showing results (381-390 of 443) with videos related to
Sort By:
Pageof 45
European Burn Journal|September 22, 2025
21st Congress of the European Burns Association (EBA)Nadia Depetris, Alette E E de Jong, Jill Meirte, et al.The Journal of Prevention of Alzheimer'S Disease|March 29, 2016
A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS)A M Wessels, E R Siemers, P Yu, et al.Acta Neuropathologica|February 12, 2011
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNILeslie M Shaw, Hugo Vanderstichele, Malgorzata Knapik-Czajka, et al.Briefings in Functional Genomics & Proteomics|June 23, 2007
Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometryValentina Gelfanova, Richard E Higgs, Robert A Dean, et al.Annals of Neurology|April 11, 2009
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous systemRandall J Bateman, Eric R Siemers, Kwasi G Mawuenyega, et al.Pharmaceutics|February 24, 2024
PEG-Lipid-PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory DrugsJana Ismail, Lea C Klepsch, Philipp Dahlke, et al.Communications Biology|January 4, 2023
Human theca arises from ovarian stroma and is comprised of three discrete subtypesNicole Lustgarten Guahmich, Limor Man, Jerry Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction CancerMing Lei, Nathan O Siemers, Dimple Pandya, et al.Journal of Alzheimer'S Disease : JAD|June 23, 2011
Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studiesD Richard Lachno, Martin J Romeo, Eric R Siemers, et al.Neurology|March 1, 2006
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseE R Siemers, J F Quinn, J Kaye, et al.Pageof 45